Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regen BioPharma (RGBP) Return on Equity (2016 - 2025)

Historic Return on Equity for Regen BioPharma (RGBP) over the last 12 years, with Q4 2025 value amounting to 0.12%.

  • Regen BioPharma's Return on Equity fell 700.0% to 0.12% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.12%, marking a year-over-year decrease of 700.0%. This contributed to the annual value of 0.22% for FY2025, which is 900.0% up from last year.
  • Regen BioPharma's Return on Equity amounted to 0.12% in Q4 2025, which was down 700.0% from 0.21% recorded in Q3 2025.
  • In the past 5 years, Regen BioPharma's Return on Equity registered a high of 0.21% during Q3 2025, and its lowest value of 0.01% during Q1 2022.
  • For the 5-year period, Regen BioPharma's Return on Equity averaged around 0.1%, with its median value being 0.1% (2024).
  • Its Return on Equity has fluctuated over the past 5 years, first surged by 1500bps in 2023, then tumbled by -800bps in 2024.
  • Over the past 5 years, Regen BioPharma's Return on Equity (Quarter) stood at 0.04% in 2021, then soared by 233bps to 0.13% in 2022, then tumbled by -38bps to 0.08% in 2023, then soared by 141bps to 0.19% in 2024, then tumbled by -38bps to 0.12% in 2025.
  • Its Return on Equity was 0.12% in Q4 2025, compared to 0.21% in Q3 2025 and 0.17% in Q2 2025.